AAAAAA
Results:
1-16
|
Results: 16
Authors:
Vanhoefer, U
Harstrick, A
Achterrath, W
Cao, SS
Seeber, S
Rustum, YM
Citation: U. Vanhoefer et al., Irinotecan in the treatment of colorectal cancer: Clinical overview, J CL ONCOL, 19(5), 2001, pp. 1501-1518
Authors:
Scheulen, ME
Hilger, RA
Oberhoff, C
Casper, J
F'reund, M
Josten, KM
Bornhauser, M
Ehninger, G
Berdel, WE
Baumgart, J
Harstrick, A
Bojko, P
Wolf, HH
Schindler, AE
Seeber, S
Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216
Authors:
Harstrick, A
Citation: A. Harstrick, Future treatment options with capecitabine, SEMIN ONCOL, 27(5), 2000, pp. 149-152
Authors:
Vanhoefer, U
Schleucher, N
Klaassen, U
Seeber, S
Harstrick, A
Citation: U. Vanhoefer et al., Ifosfamide-based drug combinations: Preclinical evaluation of drug interactions and translation into the clinic, SEMIN ONCOL, 27(1), 2000, pp. 8-13
Authors:
Hautkappe, ALA
Lu, MJ
Mueller, H
Bex, A
Harstrick, A
Roggendorf, M
Ruebben, H
Citation: Ala. Hautkappe et al., Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA, CANCER RES, 60(12), 2000, pp. 3170-3174
Authors:
Schwartz, GK
Harstrick, A
Baron, MG
Citation: Gk. Schwartz et al., Raltitrexed (Tomudex (TM)) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: Preliminary results fromphase I clinical trials, EUR J CANC, 35, 1999, pp. S9-S13
Authors:
Klaassen, U
Borquez, D
Lang, S
Oberhoff, C
Harstrick, A
Seeber, S
Benner, S
Citation: U. Klaassen et al., Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer, ONCOLOGY-NY, 13(7), 1999, pp. 71-73
Authors:
Bojko, P
Nowak, N
Moritz, T
Flasshove, M
Harstrick, A
Seeber, S
Citation: P. Bojko et al., Thrombopoietin serum levels at the start of mobilization, collection, and transfusion of autologous peripheral bleed stem cells, J CLIN APH, 14(2), 1999, pp. 57-62
Authors:
Bojko, P
Stellberg, W
Kudde, C
Scharifi, M
Herrmann, M
Mayer, S
Harstrick, A
Seeber, S
Citation: P. Bojko et al., Kinetic study of CD34+ cells during peripheral blood stem cell collections, J CLIN APH, 14(1), 1999, pp. 18-25
Authors:
Vanhoefer, U
Harstrick, A
Kohne, CH
Achterrath, W
Rustum, YM
Seeber, S
Wilke, H
Citation: U. Vanhoefer et al., Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 907-913
Authors:
Bokemeyer, C
Gerl, A
Schoffski, P
Harstrick, A
Niederle, N
Beyer, J
Casper, J
Schmoll, HJ
Kanz, L
Citation: C. Bokemeyer et al., Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer, J CL ONCOL, 17(2), 1999, pp. 512-516
Authors:
Bokemeyer, C
Kollmannsberger, C
Meisner, C
Harstrick, A
Beyer, J
Metzner, B
Hartmann, JT
Schmoll, HL
Einhorn, L
Kanz, L
Nichols, C
Citation: C. Bokemeyer et al., First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis, J CL ONCOL, 17(11), 1999, pp. 3450-3456
Authors:
Harstrick, A
Klaassen, U
Eberhardt, W
Seeber, S
Citation: A. Harstrick et al., Role of chemotherapy against micrometastatic cancer, CANC METAST, 18(1), 1999, pp. 151-172
Authors:
Bokemeyer, C
Kollmannsberger, C
Harstrick, A
Beyer, J
Gerl, A
Casper, J
Metzner, B
Hartmann, JT
Schmoll, HJ
Kanz, L
Citation: C. Bokemeyer et al., Treatment of patients with cisplatin-refractory testicular germ-cell cancer, INT J CANC, 83(6), 1999, pp. 848-851
Authors:
Vanhoefer, U
Muller, MR
Hilger, RA
Lindtner, B
Klaassen, U
Schleucher, N
Rustum, YM
Seeber, S
Harstrick, A
Citation: U. Vanhoefer et al., Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines, BR J CANC, 81(8), 1999, pp. 1304-1310
Authors:
Bokemeyer, C
Harstrick, A
Beyer, J
Metzner, B
Ruther, U
Hartmann, JT
Holstein, K
Derig, HG
De Wit, R
Casper, J
Schoffski, P
Kuhrer, I
Illiger, HJ
Kempf, B
Reichle, A
Foller, A
Hossfeld, DK
Fischer, JT
Berdel, WE
Gerhartz, HH
Kirchner, H
Pfluger, KH
Ostermann, H
Kanz, L
Schmoll, HJ
Citation: C. Bokemeyer et al., The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors, EUROCANCER 98, 1998, pp. 321-323
Risultati:
1-16
|